Tibet Weixinkang Medicine Co., Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 315.28 million compared to CNY 207.95 million a year ago. Revenue was CNY 315.28 million compared to CNY 207.95 million a year ago. Net income was CNY 38.91 million compared to CNY 18.56 million a year ago. Basic earnings per share from continuing operations was CNY 0.09 compared to CNY 0.04 a year ago. Diluted earnings per share from continuing operations was CNY 0.09 compared to CNY 0.04 a year ago.